Every 30 seconds, someone in the world will experience a flare-up of their asthma or chronic obstructive pulmonary disease ...

Study, published in The Lancet Respiratory Medicine, has revealed that a drug called benralizumab - administered as an ...

When a person’s asthma is severe or isn’t managed well by typical protocols, they may be a good candidate for pulmonary ...

your symptoms happen when you come into contact with an asthma trigger, like pollen or animals or when you have a cold or ...

Chronic obstructive pulmonary disease, or COPD, is a leading cause of disability and death in the U.S., according to the ...

Asthma and chronic obstructive pulmonary disease (COPD) are significant health challenges, with asthma affecting around ...

The study demonstrated that asthma treatment is safe, with no significant side effects compared to past studies of the drug.

Scientists have found a new treatment for people with asthma and chronic obstructive pulmonary disease (COPD) that may be more effective than current options. Over the past 50 years, treatment options ...

Benralizumab is a monoclonal antibody that targets specific white blood cells, called eosinophils, to reduce lung ...

The main advances in asthma management are related to different strategies for improved disease control ... also many nonpharmacologic strategies (pulmonary rehabilitation [PR], mechanical ...

Certain chronic conditions that affect the lungs, such as asthma and chronic obstructive pulmonary disease (COPD), can have ...